Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of €124.02 million as of November 22, 2024. Its market cap has decreased by -29.92% in one year.

Market Cap

124.02M

Enterprise Value

67.72M

Revenue

33.79M

Ranking

n/a

PE Ratio

n/a

Stock Price

€1.53

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 124.02M, an increase of 15,556.29%. That is a compound annual growth rate of 32.28%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	128.23M	-39.30%
Dec 29, 2023	211.24M	-19.93%
Dec 30, 2022	263.84M	-24.98%
Dec 31, 2021	351.67M	28.64%
Dec 31, 2020	273.37M	-41.60%
Dec 31, 2019	468.11M	-1.49%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sanofi	113.83B
EssilorLuxottica Société anonyme	106.51B
Sartorius Stedim Biotech S.A.	16.35B
bioMérieux S.A.	11.51B
Ipsen S.A.	8.83B
Eurofins Scientific SE	8.68B
Virbac SA	2.66B
Ramsay Générale de Santé SA	1.28B

Market Cap Rankings